Sionna Therapeutics initiated with a Buy at TD Cowen
TD Cowen initiated coverage of Sionna Therapeutics (SION) with a Buy rating. Sionna’s pipeline of cystic fibrosis therapies directly target ...
Goldman Sachs starts Sionna Therapeutics with Early-Stage Biotech designation
Goldman Sachs initiated coverage of Sionna Therapeutics (SION) with an Early-Stage Biotech designation. Lead assets SION-719 and SION-451 are ...
5 Top Stocks to Buy in March
U.S.-based companies are dragging down the major stock market indexes. But getting caught up in short-term market movements ...
Pharmabiz14h
Vertex Pharma receives CHMP positive opinion for label expansion of Kaftrio in combination with ivacaftor
Vertex Pharma receives CHMP positive opinion for label expansion of Kaftrio in combination with ivacaftor: London Tuesday, March 4, 2025, 14:00 Hrs [IST] Vertex Pharmaceuticals, a ...